LogicBio Therapeutics, Inc. (19)

Browse by Contract Category

Contracts

Form of Executive Employment Agreement, by and between LogicBio Therapeutics, Inc. and Cecilia Jones (Filed With SEC on March 15, 2021)
Amendment No. 5 to Amended and Restated (Equity) Agreement, dated as of October 30, 2020, between The Board of Trustees of the Leland Stanford University and LogicBio... (Filed With SEC on March 15, 2021)
Amendment No.2 to Patent & Technology License Agreement, dated September 29, 2020, by and between LogicBio Therapeutics, Inc. and The Board of Regents of The University of Texas... (Filed With SEC on November 9, 2020)
Second Amendment to Loan and Security Agreement, dated September 28, 2020, by and between the Company, LogicBio Australia Pty Limited, Oxford Finance LLC and Horizon Credit II LLC (Filed With SEC on November 9, 2020)
Lease Agreement dated as of November 4, 2019, between LogicBio Therapeutics, Inc. and HCP/King Hayden Campus LLC (Filed With SEC on March 16, 2020)
First Amendment to Loan and Security Agreement, dated April 23, 2020, by and between the Company, LogicBio Australia Pty Limited, Oxford Finance LLC and Horizon Credit II LLC (Filed With SEC on November 9, 2020)
Underwriting Agreement, dated October 1, 2020, among LogicBio Therapeutics, Inc. and Jefferies LLC, Barclays Capital Inc., and William Blair & Company, L.L.C., as representatives... (Filed With SEC on October 5, 2020)
Amendment No 4 to Amendment and Restated (Equity) Agreement, dated as of April 29, 2020, between The Board of Trustees of the Leland Stanford University and LogicBio Therapeutics,... (Filed With SEC on August 10, 2020)
Amended and Restated Executive Employment Agreement, by and between LogicBio Therapeutics, Inc. and Kenneth Huttner (Filed With SEC on May 11, 2020)
Form of Executive Employment Agreement, by and between LogicBio Therapeutics, Inc. and Seokho Bryan Yoon (Filed With SEC on March 16, 2020)
Amendment No. 1 to Patent & Technology License Agreement, dated October 14, 2019, by and between LogicBio Therapeutics, Inc. and The Board of Regents of Thu University of Texas... (Filed With SEC on March 16, 2020)
Amendment No. 3 to Amended and Restated (Equity) Agreement, dated as of January 29, 2020, between The Board of Trustees of the Leland Stanford University and LogicBio... (Filed With SEC on March 16, 2020)
Amendment No. 1 to Amended and Restated (Equity) Agreement, dated as of May 3, 2018, between The Board of Trustees of the Leland Stanford University and LogicBio Therapeutics, Inc (Filed With SEC on March 16, 2020)
Description of the Registrants Securities (Filed With SEC on March 16, 2020)
Amended and Restated Executive Employment Agreement, by and between LogicBio Therapeutics, Inc. and Dean Falb (Filed With SEC on November 12, 2019)
Amendment No. 2 to the Amended and Restated Exclusive (Equity) Agreement, dated as of June 24, 2019, between the Company and The Board of Trustees of the Leland Stanford University (Filed With SEC on August 13, 2019)
Loan and Security Agreement dated as of July 2, 2019, among Oxford Finance LLC, the Lenders listed on Schedule 1.1 thereto and Horizon Technology Finance Corporation and LogicBio... (Filed With SEC on July 2, 2019)
Form of Warrant to Purchase Common Stock of LogicBio Therapeutics, Inc., dated as of July 2, 2019 (Filed With SEC on July 2, 2019)
Patent License Agreement dated December 14, 2018, between the U.S. Department of Health and Human Services, as represented by the National Human Genome Research Institute, an... (Filed With SEC on April 1, 2019)